Women's Screening and Self-Testing Program (PROMETA)
Part of Cancer, Immune system & allergy, Infections, Women’s health & pregnancy clinical trials.
This study tests a self-screening program for cervical cancer among women who are already receiving HIV care. It aims to make screening easier and more accessible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 25 and 49 years old.
- You are currently accessing HIV care and treatment services.
- You are not pregnant.
- You still have your cervix (have not had a total hysterectomy).
- You do not have a physical or mental condition that would prevent you from taking part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether letting people collect their own HPV test sample (a private, at-home option) makes cervical cancer screening easier for people with HIV and/or those who are often underserved. If you’ve declined a Pap test or it’s been 6+ months since your last screening, this may offer a more convenient way to check for HPV and cervical cancer risk.
This trial compares two ways to help women with HIV get screened for cervical cancer: a clinic-based approach versus a combined clinic and community outreach program. You may be able to provide samples yourself at a clinic or at home to test for HPV, the virus that can cause cervical cancer.
This study tests a self-collection kit for HPV, a virus that can cause cervical cancer. It aims to make screening easier for women with HIV who haven't had a Pap test recently, and to find earlier signs of risk.
This trial compares two ways to help women living with HIV get screened for cervical cancer: one uses only clinic visits, the other adds community outreach and self-testing for HPV at home. It aims to increase screening rates and catch early signs of cervical cancer.
This study looks at different ways for people to collect their own samples for cervical cancer screening (HPV testing) at home or wherever they are. It aims to make screening easier and more accessible for people who are unhoused or in unstable housing.
This trial tests a new way to screen for cervical cancer using a self-collected sample at home. It aims to find high-risk HPV types early to prevent cancer.
Hear when a new Human Papilloma Virus Related Cervical Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.